← Back to directory

Anil Kapoor

Researcher Next ID · RN-037549

Researcher · Biochemistry, Genetics and Molecular Biology

People’s University

Bhopal, India

Accepting doctoral researchersFunding unknown
Works count
635
Citation count
16,456
H-index
55
i10-index
255

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Renal cell carcinoma treatment
Bladder and Urothelial Cancer Treatments
Renal and related cancers
Prostate Cancer Treatment and Research
Multiple and Secondary Primary Cancers

Publications

  • Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study

    The Lancet Oncology · 2023 · 10.1016/s1470-2045(23)00049-9

  • Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium

    European Urology · 2022 · 10.1016/j.eururo.2022.10.004

  • Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

    New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2035716

  • Contributions of DNA Damage to Alzheimer’s Disease

    International Journal of Molecular Sciences · 2020 · 10.3390/ijms21051666

  • The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis

    Cancers · 2019 · 10.3390/cancers11040434

  • Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline

    The Journal of Urology · 2019 · 10.1097/ju.0000000000000296

  • Enzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies

    PLoS ONE · 2017 · 10.1371/journal.pone.0173358

  • Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma

    JAMA Oncology · 2016 · 10.1001/jamaoncol.2016.4419

  • The 2014 CUA-CUOG Guidelines for the Management of Castration Resistant Prostate Cancer (CRPC)

    Canadian Urological Association Journal · 2015 · 10.5489/cuaj.2526

  • Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities

    Blood · 2014 · 10.1182/blood-2014-07-590844

  • Conditional Survival After Radical Nephroureterectomy for Upper Tract Carcinoma

    European Urology · 2014 · 10.1016/j.eururo.2014.08.003

  • Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression

    Oncotarget · 2014 · 10.18632/oncotarget.2953

  • Guidelines for the diagnosis and management of recurrent urinary tract infection in women

    Canadian Urological Association Journal · 2013 · 10.5489/cuaj.687

  • Regulation of the Tumor Suppressor PTEN through Exosomes: A Diagnostic Potential for Prostate Cancer

    PLoS ONE · 2013 · 10.1371/journal.pone.0070047

  • Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta‐analysis of case series studies

    British Journal of Urology · 2012 · 10.1111/j.1464-410x.2011.10885.x

  • Guidelines for the diagnosis and management of recurrent urinary tract infection in women

    Canadian Urological Association Journal · 2011 · 10.5489/cuaj.11214

  • Guidelines for the management of the incidentally discovered adrenal mass

    Canadian Urological Association Journal · 2011 · 10.5489/cuaj.11135

  • Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells

    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2011 · 10.1016/j.bbamcr.2011.01.018

  • Lower Plasma Adiponectin Levels Are Associated with Larger Tumor Size and Metastasis in Clear-Cell Carcinoma of the Kidney

    European Urology · 2008 · 10.1016/j.eururo.2008.02.044

  • Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

    New England Journal of Medicine · 2007 · 10.1056/nejmoa066838

  • A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR + IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (adv RCC)

    Journal of Clinical Oncology · 2006 · 10.1200/jco.2006.24.18_suppl.lba4

  • Role of computed tomography with no contrast medium enhancement in predicting the outcome of extracorporeal shock wave lithotripsy for urinary calculi

    British Journal of Urology · 2005 · 10.1111/j.1464-410x.2005.05520.x

  • Prevention of mother to child transmission of HIV

    The Indian Journal of Pediatrics · 2004 · 10.1007/bf02724278

  • Apoptotic Release of Histones from Nucleosomes

    Journal of Biological Chemistry · 2002 · 10.1074/jbc.m109219200

  • Early Chemokine Cascades in Murine Cardiac Grafts Regulate T Cell Recruitment and Progression of Acute Allograft Rejection

    The Journal of Immunology · 2001 · 10.4049/jimmunol.167.5.2979

Current projects

    No projects listed.